Press Releases

 Filter by Provider

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming investor events:

MONTRÉAL, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Morocco Strategic Minerals Corporation (TSXV: MCC) ("MCC" or the "Corporation") is pleased to announce that it has entered on September 2, 2026 into a revised property purchase and option agreement (the “Agreement”) with Visible Gold Mines Inc. (TSXV: VGD) (“Visible Gold”) pursuant to which Visible Gold acquired a 51% interest in the Sakami Property (“Sakami” or the “Property”) and was granted an exclusive option to acquire the 49% remaining interest therein subject to the receipt of the Corporation’s shareholders approval (the “Transaction”). The Agreement revises the initial agreement previously announced on May 26, 2026, to provide for completion of the Transaction in two closings. The Property is located in the James Bay region of Québec.

MILLBRAE, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today announced the appointment of Ching-Pin (“CP”) Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer.

The New York Stock Exchange, part of Intercontinental Exchange, Inc. (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets, and Korea Exchange, the sole securities exchange operator in the Republic of Korea, today announced the signing of a memorandum of understanding to collaborate on a number of key business activities aimed at expanding access to global capital markets.

JOHNS CREEK, Ga., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Saia, Inc. (Nasdaq: SAIA) is providing LTL shipment and tonnage data for the first two months of the third quarter. In July 2026, LTL shipments per workday increased 0.8%, LTL tonnage per workday increased 7.8% and LTL weight per shipment increased 7.0%, each compared to July 2025. In August 2026, LTL shipments per workday increased 1.1%, LTL tonnage per workday increased 8.7% and LTL weight per shipment increased 7.5%, each compared to August 2025.

VSE Corporation (“VSE” or the “Company”) (NASDAQ: VSEC, VSECU), a leading provider of aviation aftermarket distribution and repair services, announced today that VSE Corporation’s senior management will participate in the following upcoming conferences.

WALTHAM, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in September:

- Data support the ongoing development of four investigational therapies for DMD amenable to skipping of exons 53, 45, 44 or 55, all of which are advancing into IND-enabling studies -

Termination of two leases in the United States and Israel further reduces fixed costs and strengthens operating flexibility

MORRISVILLE, N.C., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to YUTREPIA® (treprostinil) inhalation powder for the treatment of Raynaud's phenomenon associated with systemic sclerosis (SSc-RP). The potential use of YUTREPIA in SSc-RP is currently under clinical development, and its safety and efficacy for this indication have not been evaluated by any regulatory authority.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Shanghai, China--(Newsfile Corp. - September 3, 2026) - Frost & Sullivan, in partnership with TradeGo, LeadLeo and CCXGF (China Chengxin...

VANCOUVER, BC / ACCESS Newswire / September 3, 2026 / Spirit Blockchain Capital Inc. (CSE:SPIR)(OTCQB:SBLCF) ("Spirit" or the "Company"), further to its news release dated August 27, 2026, announces that it has completed the previously announced shares-for-services settlement through the issuance of an aggregate of 4,300,300 common shares of the Company (the "Shares") at a deemed price of $0.05 per Share, representing an aggregate value of $215,015, in full satisfaction of outstanding obligations for services previously provided to the Company.

The Campbell's Company (NASDAQ:CPB) today reported results for its fourth quarter fiscal 2026 ended August 2, 2026. Unless otherwise stated, all comparisons are to the comparable period in fiscal 2025. The La Regina acquisition was completed on May 4, 2026, and as such, La Regina's financials are fully consolidated into Campbell's results.

25th MiniLuxe opens in Mansfield, MA

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

New analysis finds land and ocean sinks are weakening and carbon prices and coverage fall short of what is needed to protect them, leaving net zero strategies built on unverified foundations

Advancing the City's Development as an International Hub for High-Caliber Talent

VANCOUVER, BC / ACCESS Newswire / September 3, 2026 / Faraday Copper Corp. ("Faraday" or the "Company") (TSX:FDY)(OTCQX:CPPKF) is pleased to announce the results of 23 drill holes from its Phase IV drill program at the Copper Creek Project, located in Arizona ("Copper Creek"). Eight holes were drilled near Copper Giant and targeted near-surface copper mineralization; five holes were drilled in the American Eagle area targeting near-surface mineralization and one previously undrilled breccia trend; three holes were drilled in the Old Reliable area targeting structural trends west and north of the known mineralization; six holes were drilled near Mammoth and Childs Aldwinkle and had infill and geotechnical objectives; and one hydrogeological hole was drilled in the southern part of the property, near the Sunrise trend (Figure 1).

BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, has received Frost & Sullivan's 2026 United States Technology Innovation Leadership Recognition in the Technology-Enabled Care Platforms Industry. The recognition validates Amwell's ability to address healthcare fragmentation through a unified platform that orchestrates consumer experiences, clinician workflows, care programs, and partner solutions.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

MELBOURNE, Australia and SAN FRANCISCO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer, will participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026 on Friday, September 11, 2026 at 10:20 a.m. ET in the United States.

It’s 6:12 a.m. One kid is already sprinting down the hallway. Another has to be dragged out of bed by the ankles. Dad’s hunting for a slipper that’s vanished overnight, and Mom’s already three sips into her coffee before anyone else is even upright. Christmas morning has a way of starting on everybody’s own schedule — except the camera doesn’t wait for that.

NEW HAVEN, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on September 1, 2026, Invivyd granted six newly hired non-executive employees options to purchase an aggregate of 255,000 shares of its common stock, each as a material inducement for each employee’s entry into employment with Invivyd. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4) and pursuant to the Invivyd, Inc. 2026 Inducement Plan. 

Cellgenic is expanding local representation and commercial support in Brazil, one of Latin America's larger healthcare and aesthetic-medicine markets. ISSCA continues to hold physician-education events in São Paulo. Activities in Brazil remain subject to applicable local law and regulatory requirements.

JACKSONVILLE, Fla., Sept. 3, 2026 (SEND2PRESS NEWSWIRE) -- Dark Matter Technologies (Dark Matter), an innovative leader in mortgage technology, today announced it has expanded its leadership team with two experienced executives: Salvatore Piccola as senior vice president of product strategy and Gil Valera as vice president of professional services. The additions strengthen two areas central to Dark Matter's growth strategy: innovation focused on using AI to improve customer experience, help lenders realize efficiencies, and drive seamless implementation and adoption of its product capabilities.

London, Ontario--(Newsfile Corp. - September 3, 2026) - VersaBank (TSX: VBNK) (NASDAQ: VBNK) (the "Bank") today announced that cash dividends in the...

- Bank Targets Adding at Least US$3 Billion in US SRP in Fiscal 2027 and Accelerated Growth in Canada --...

Ciena® Corporation (NYSE: CIEN) today announced financial results for its fiscal third quarter ended August 1, 2026.

VANCOUVER, BC / ACCESS Newswire / September 3, 2026 / North Shore Uranium Ltd. (TSXV:NSU)(OTCQB:NSURF) ("North Shore" or the "Company") is pleased to report drill results from Phase 1 of its first drill program at the Rio Puerco uranium project in the Grants Uranium District of northwestern New Mexico ("Rio Puerco" or the "Project"). As reported on August 13, 2026, the Company completed 13 rotary drill holes totaling 9,274 ft. (2,828 m).

Polestar (Nasdaq: PSNY) presents its consolidated financial results and operational metrics for the three-month and six-month periods ended June 30, 2026.

Albany Engineered Composites, a segment of Albany International Corp. (NYSE: AIN), announced today it reached an agreement with Boeing (NYSE: BA) to continue composite fuselage frame manufacturing for the 787 Dreamliner.

Vince Holding Corp., (Nasdaq: VNCE) (“VNCE” or the “Company”), a global retail platform, today announced that it plans to report its second quarter 2026 financial results pre-market on Thursday, September 10, 2026. The Company also plans to hold a conference call to discuss its financial results on the same day at 8:30 a.m. ET. During the conference call, the Company may answer questions concerning business and financial developments, trends and other business or financial matters. The Company's responses to these questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been previously disclosed.

ProCap Financial, Inc. (Nasdaq: BRR), the first publicly traded agentic finance firm, today announced it repurchased two percent of shares of its common stock at an approximate 40% discount to Net Asset Value (“NAV”). The Company funded the repurchases by selling approximately 50 Bitcoin. Since the start of its share buyback program, approximately 10% of shares outstanding have been repurchased.

Honeywell Technologies (NASDAQ: HON) today announced its participation at the Morgan Stanley Laguna Conference in Dana Point, California. On Tuesday, September 15, 2026, Vimal Kapur, Chairman and Chief Executive Officer, and Mike Stepniak, Senior Vice President and Chief Financial Officer, will present from 11:30 a.m. - 12:05 p.m. PDT (2:30 p.m. - 3:05 p.m. EDT). A real-time webcast of the presentation can be accessed at investor.honeywell.com, where related materials will be posted following the presentation and a replay of the webcast will be available for 30 days following the presentation.

AEye, Inc. (Nasdaq: LIDR), a global leader in software-defined, high-performance lidar solutions, today announced that CFO Conor Tierney will present and host one-on-one investor meetings at the 28th Annual H.C. Wainwright Global Investment Conference on September 14-16, 2026 at the Lotte New York Palace Hotel in New York City.

Equity Bancshares, Inc. (NYSE: EQBK), (“Equity,” the “Company,” “we,” “us,” “our”), the Wichita-based holding company of Equity Bank, along with Lincoln Bancorp (“Lincoln”), the parent company of Lincoln Savings Bank, headquartered in Reinbeck, Iowa, announced today they have entered into a definitive merger agreement for Lincoln to merge with and into Equity, adding 16 locations to Equity’s franchise. This transaction builds upon Equity’s Iowa presence, providing a platform for expansion in the state.

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing genetic medicines for rare and devastating diseases, focused on inherited cardiovascular disorders, today announced that the Company will participate in the 2026 Cantor Global Healthcare Conference and the Morgan Stanley 24th Annual Global Healthcare Conference in New York.

Old Dominion Freight Line, Inc. (Nasdaq: ODFL) today reported certain less-than-truckload (“LTL”) operating metrics for August 2026. Revenue per day increased 12.4% as compared to August 2025 due to an increase in our LTL revenue per hundredweight that was partially offset by a 0.9% decrease in LTL tons per day. The change in LTL tons per day was attributable to a 2.4% decrease in LTL shipments per day that was partially offset by a 1.7% increase in LTL weight per shipment. For the quarter-to-date period, LTL revenue per hundredweight and LTL revenue per hundredweight, excluding fuel surcharges, increased 11.3% and 4.8%, respectively, as compared to the same period last year.

SAN DIEGO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. (Nasdaq: BLSM), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative small molecule medicines for the treatment of cancer, today announced that it will present at the 8th Annual RAS-Targeted Drug Development Summit and the H.C. Wainwright 28th Annual Global Investment Conference.

SAN DIEGO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that management will participate in a fireside chat at the 2026 Annual Cantor Global Healthcare Conference, being held September 9–12, 2026 in New York, NY. Discussion topics will include an overview of the differentiated and favorable tolerability and meaningful clinical activity seen with FT819, the Company’s off-the-shelf CAR T-cell product candidate for the treatment of various autoimmune diseases. The conversation will also focus on the commencement of RECLAIM-LN, the Phase 2 potentially registrational trial in lupus nephritis, as well as the unique safety elements that are incorporated into the design of FT819. Management will also host one-on-one meetings with investors during the conference.

Balaji Rangaswamy joins GXO in newly created role of Chief Information Officer

IND submitted to FDA for Eledon-sponsored, registrational study of tegoprubart in islet cell transplantation for patients with type 1 diabetes

MINNETONKA, Minn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Nu-Tek BioSciences, the leader in 100% animal-origin-free (AOF) peptones and protein hydrolysates, will meet with biotech experts at CPHI Global 2026, taking place October 6-8, 2026, in Milan, Italy. Nu-Tek will host in-depth discussions with key stakeholders responsible for sourcing, qualifying and purchasing raw materials for cell culture media, with a focus on quality, consistency, and regulatory-friendly supply.

WATERTOWN, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that new biomarker data on the immunomodulatory effects of cemsidomide in combination with dexamethasone from its Phase 1 trial for relapsed/refractory multiple myeloma (RRMM) will be presented in a poster at the 23rd IMS Annual Meeting. The data characterize the immune effects on T cells and natural killer (NK) cells across the once-daily dose levels evaluated in the Phase 1 trial, further supporting cemsidomide’s potential as a combination partner for immune-based therapies. The meeting will take place in Glasgow, Scotland from September 23 – 26, 2026.

TORONTO and HOUSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer, autoimmune, and inflammatory diseases, announced today that Dr. Fahar Merchant, President and CEO of Medicenna, will present and participate in one-on-one meetings at the H.C. Wainwright 28th Annual Global Investment Conference, taking place September 14-16, 2026, at the Lotte New York Palace Hotel in New York City.

SAN DIEGO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (Gyre, Gyre Therapeutics or the Company) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company with operations in the United States and China, today announced that Company management will participate in the Cantor Global Healthcare Conference and the Morgan Stanley Healthcare Conference, both being held this month in New York, NY. Information about both conferences is below:

~29-day half-life

BOTHELL, Wash., Sept. 03, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that Company management will participate in the Cantor Global Healthcare Conference 2026, taking place September 9-11, 2026 in New York, NY. Details are as follows: